Prognostic value of 1q21 amplification in multiple myeloma
Aim. To determine the prevalence of amp1q21 and its relationship to the clinical manifestations of multiple myeloma (MM). Subjects and methods. In December 2009 to March 2016, a total 134 patients aged 30 to 81 years (median 57 years) underwent a pretreatment FISH-study of bone marrow (BM) with cent...
Main Authors: | T V Abramova, T N Obukhova, L P Mendeleeva, O S Pokrovskaya, E O Gribanova, V V Ryzhko, L A Grebenyuk, M V Nareyko, M V Solovyev, O M Votyakova, S M Kulikov, M A Rusinov, V G Savchenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2017-07-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/32260/pdf |
Similar Items
-
The amplification of 1q21 is an adverse prognostic factor in patients with multiple myeloma in a Chinese population
by: Yu W, et al.
Published: (2016-01-01) -
Genetic aberrations in multiple myeloma characterized by cIg-FISH: a Brazilian context
by: P. Segges, et al.
Published: (2016-01-01) -
Infectious complications in patients with multiple myeloma on first chemotherapy cycle
by: A. A. Novikova, et al.
Published: (2018-10-01) -
Chromosomal aberrations in multiple myeloma: A study on Indian population
by: Angel Beula P. Royal, et al.
Published: (2018-01-01) -
Structure and significance of cytogenetic abnormalities in adult patients with Ph-negative acute lymphoblastic leukemia
by: I S PISKUNOVA, et al.
Published: (2018-07-01)